HOLON, Israel (AP) — HOLON, Israel (AP) — Compugen Ltd. (CGEN) on Monday reported a loss of $3.1 million in its fourth quarter.
The Holon, Israel-based company said it had a loss of 4 cents per share.
The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 14 cents per share.
The drug developer posted revenue of $7.5 million in the period.
For the year, the company reported that its loss narrowed to $33.7 million, or 39 cents per share. Revenue was reported as $7.5 million.
The company’s shares closed at 75 cents. A year ago, they were trading at $3.02.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CGEN at https://www.zacks.com/ap/CGEN
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
